What can Rishi Sunak do for the UK’s pharma industry
Pharmaceutical Technology
NOVEMBER 4, 2022
At the time of its publication, the document prioritised the finalisation of Brexit above all else. For the life sciences and pharmaceutical sector, the Conservative government promised £34 billion ($38.98 of gross domestic product (GDP) in R&D by 2027. UK’s competitive potential.
Let's personalize your content